American Journal of Clinical Pathology · 2007 · 165 citations · 29 references
MedicinePathologyPediatricsClinical BiochemistryMolecular PathologyPediatric PathologyBiomarkers Of Liver InjuryHepatic PathologyLiver DiseaseLiver Function TestsMetabolic Liver DiseasePediatric Liver DiseaseBiomarkers Of SeverityHepatic Steatosis AssessmentLaboratory Marker AssessmentLiver Disease Risk AssessmentNonalcoholic Fatty Liver Disease AssessmentSteatosis QuantificationUnivariate AnalysisUnivariate Risk Analysis
We tested the power of tumor necrosis factor (TNF)-alpha and/or leptin in predicting the degree of liver involvement in children with nonalcoholic fatty liver disease (NAFLD). We measured serum levels of TNF-alpha and leptin and computed NAFLD activity score (NAS) (NAS >or= 5, diagnostic of nonalcoholic steatohepatitis [NASH]) in 72 consecutive biopsy-proven NAFLD cases (training and validation sets, 36 cases each). Univariate analysis evaluated variables significantly associated with a diagnostic NAS. Receiver operating characteristic (ROC) curve analysis assessed the diagnostic value of selected variables in predicting a NAS of 5 or more.TNF-alpha (P < .0001), leptin (P = .001); triglycerides (P = .013), and alkaline phosphatase (P = .046) levels were significantly associated with a NAS of 5 or more. TNF-alpha and leptin levels predicted the risk of NAS of 5 or more. ROC analyses defined cutoff values for TNF-alpha, leptin, and risk score. They identified 90%, 83%, and 83% of the cases, respectively, with a NAS of 5 or more (true-positive cases) from the validation set.TNF-alpha alone or combined with leptin in a simple risk score can accurately predict a NAS of 5 or more. TNF-alpha seems to be a specific laboratory marker of NASH.
29
Establishing a standard definition for child overweight and obesity worldwide: international survey
Tim Cole · BMJ · 2000 · 16.5K citations · Full text
Medicine, Child Health, Pediatrics +16
Practical Statistics for Medical Research.
Sophie Walter, Daniel Altman · Biometrics · 1992 · 11.7K citations
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology · 2005 · 10.7K citations